Skip to main content
Fig. 3 | Journal of Nanobiotechnology

Fig. 3

From: Artificial exosomes for translational nanomedicine

Fig. 3

(Reprinted with permission from Ref. [90]Copyright Royal Society of Chemistry, 2019)

A typical bottom-up strategy for generating fully artificial exosomes for drug delivery. Hybrid membrane proteins from red blood cells and cancer cells were integrated into liposomes during preparation to form artificial chimeric exosomes (ACEs). ACEs have anti-phagocytosis ability during circulation (from red blood cell) and the tumor-homing ability (from cancer cell) for targeted drug delivery.

Back to article page